BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 25838542)

  • 1. miR-182 integrates apoptosis, growth, and differentiation programs in glioblastoma.
    Kouri FM; Hurley LA; Daniel WL; Day ES; Hua Y; Hao L; Peng CY; Merkel TJ; Queisser MA; Ritner C; Zhang H; James CD; Sznajder JI; Chin L; Giljohann DA; Kessler JA; Peter ME; Mirkin CA; Stegh AH
    Genes Dev; 2015 Apr; 29(7):732-45. PubMed ID: 25838542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRNA-182 and the regulation of the glioblastoma phenotype - toward miRNA-based precision therapeutics.
    Kouri FM; Ritner C; Stegh AH
    Cell Cycle; 2015; 14(24):3794-800. PubMed ID: 26506113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastoma.
    Jensen SA; Day ES; Ko CH; Hurley LA; Luciano JP; Kouri FM; Merkel TJ; Luthi AJ; Patel PC; Cutler JI; Daniel WL; Scott AW; Rotz MW; Meade TJ; Giljohann DA; Mirkin CA; Stegh AH
    Sci Transl Med; 2013 Oct; 5(209):209ra152. PubMed ID: 24174328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of miRNAs in the differentiation of human glioblastoma multiforme stem-like cells.
    Aldaz B; Sagardoy A; Nogueira L; Guruceaga E; Grande L; Huse JT; Aznar MA; Díez-Valle R; Tejada-Solís S; Alonso MM; Fernandez-Luna JL; Martinez-Climent JA; Malumbres R
    PLoS One; 2013; 8(10):e77098. PubMed ID: 24155920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-128-3p Enhances the Chemosensitivity of Temozolomide in Glioblastoma by Targeting c-Met and EMT.
    Zhao C; Guo R; Guan F; Ma S; Li M; Wu J; Liu X; Li H; Yang B
    Sci Rep; 2020 Jun; 10(1):9471. PubMed ID: 32528036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-144-3p exerts anti-tumor effects in glioblastoma by targeting c-Met.
    Lan F; Yu H; Hu M; Xia T; Yue X
    J Neurochem; 2015 Oct; 135(2):274-86. PubMed ID: 26250785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A first-in-human phase 0 clinical study of RNA interference-based spherical nucleic acids in patients with recurrent glioblastoma.
    Kumthekar P; Ko CH; Paunesku T; Dixit K; Sonabend AM; Bloch O; Tate M; Schwartz M; Zuckerman L; Lezon R; Lukas RV; Jovanovic B; McCortney K; Colman H; Chen S; Lai B; Antipova O; Deng J; Li L; Tommasini-Ghelfi S; Hurley LA; Unruh D; Sharma NV; Kandpal M; Kouri FM; Davuluri RV; Brat DJ; Muzzio M; Glass M; Vijayakumar V; Heidel J; Giles FJ; Adams AK; James CD; Woloschak GE; Horbinski C; Stegh AH
    Sci Transl Med; 2021 Mar; 13(584):. PubMed ID: 33692132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemo-resistance of A172 glioblastoma cells is controlled by miR-1271-regulated Bcl-2.
    Yang L; Wang Y; Li YJ; Zeng CC
    Biomed Pharmacother; 2018 Dec; 108():734-740. PubMed ID: 30248541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-mediated mitochondria apoptosis inhibition induces temozolomide treatment resistance through miR-26a/Bad/Bax axis.
    Ge X; Pan MH; Wang L; Li W; Jiang C; He J; Abouzid K; Liu LZ; Shi Z; Jiang BH
    Cell Death Dis; 2018 Nov; 9(11):1128. PubMed ID: 30425242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mir-370-3p Impairs Glioblastoma Stem-Like Cell Malignancy Regulating a Complex Interplay between HMGA2/HIF1A and the Oncogenic Long Non-Coding RNA (lncRNA) NEAT1.
    Lulli V; Buccarelli M; Ilari R; Castellani G; De Dominicis C; Di Giamberardino A; D Alessandris QG; Giannetti S; Martini M; Stumpo V; Boe A; De Luca G; Biffoni M; Marziali G; Pallini R; Ricci-Vitiani L
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functionalized nanogels carrying an anticancer microRNA for glioblastoma therapy.
    Shatsberg Z; Zhang X; Ofek P; Malhotra S; Krivitsky A; Scomparin A; Tiram G; Calderón M; Haag R; Satchi-Fainaro R
    J Control Release; 2016 Oct; 239():159-68. PubMed ID: 27569663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-29b attenuates tumorigenicity and stemness maintenance in human glioblastoma multiforme by directly targeting BCL2L2.
    Chung HJ; Choi YE; Kim ES; Han YH; Park MJ; Bae IH
    Oncotarget; 2015 Jul; 6(21):18429-44. PubMed ID: 26155940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-340 suppresses glioblastoma multiforme.
    Huang D; Qiu S; Ge R; He L; Li M; Li Y; Peng Y
    Oncotarget; 2015 Apr; 6(11):9257-70. PubMed ID: 25831237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome Editing Reveals Glioblastoma Addiction to MicroRNA-10b.
    El Fatimy R; Subramanian S; Uhlmann EJ; Krichevsky AM
    Mol Ther; 2017 Feb; 25(2):368-378. PubMed ID: 28153089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bcl2L12 inhibits post-mitochondrial apoptosis signaling in glioblastoma.
    Stegh AH; Kim H; Bachoo RM; Forloney KL; Zhang J; Schulze H; Park K; Hannon GJ; Yuan J; Louis DN; DePinho RA; Chin L
    Genes Dev; 2007 Jan; 21(1):98-111. PubMed ID: 17210792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiling cytotoxic microRNAs in pediatric and adult glioblastoma cells by high-content screening, identification, and validation of miR-1300.
    Boissinot M; King H; Adams M; Higgins J; Shaw G; Ward TA; Steele LP; Tams D; Morton R; Polson E; da Silva B; Droop A; Hayes JL; Martin H; Laslo P; Morrison E; Tomlinson DC; Wurdak H; Bond J; Lawler SE; Short SC
    Oncogene; 2020 Jul; 39(30):5292-5306. PubMed ID: 32555332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
    Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
    J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal.
    Lulli V; Buccarelli M; Martini M; Signore M; Biffoni M; Giannetti S; Morgante L; Marziali G; Ilari R; Pagliuca A; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L
    Oncotarget; 2015 Nov; 6(35):37241-56. PubMed ID: 26437223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-149 is epigenetically silenced tumor-suppressive microRNA, involved in cell proliferation and downregulation of AKT1 and cyclin D1 in human glioblastoma multiforme.
    Ghasemi A; Fallah S; Ansari M
    Biochem Cell Biol; 2016 Dec; 94(6):569-576. PubMed ID: 27783537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-708 acts as a tumor suppressor in human glioblastoma cells.
    Guo P; Lan J; Ge J; Nie Q; Mao Q; Qiu Y
    Oncol Rep; 2013 Aug; 30(2):870-6. PubMed ID: 23754151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.